NCT06952660 2026-03-12
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Pfizer
Phase 4 Recruiting
Pfizer
DL Analytics
Stanford University
Karolinska Institutet
Fondazione Policlinico Universitario Agostino Gemelli IRCCS